CRNX - Crinetics Pharmaceuticals, Inc.

QQQ $ 468.16 $ -5.41 (-1.13 %)

DIA $ 411.36 $ -1.55 (-0.38 %)

SPY $ 558.32 $ -3.26 (-0.58 %)

TLT $ 97.88 $ -0.12 (-0.12 %)

GLD $ 231.76 $ -1.64 (-0.7 %)

Previous Close

$ 54.4

Open

$ 54.41

Bid

$ 54.40 x 100

Ask

-- x --

Day's Range

$ 54.02 - $ 55.53

52 Week Range

$ 15.76 - $ 55.78

Volume

441,228

Average Volume

Market Cap

2.93B

Beta (5Y Monthly)

$ 0.88

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-08-2024	06-30-2024	10-Q
2	05-09-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-09-2023	03-31-2023	10-Q
7	02-28-2023	12-31-2022	10-K
8	11-14-2022	09-30-2022	10-Q
9	08-12-2022	06-30-2022	10-Q
10	05-12-2022	03-31-2022	10-Q
11	03-30-2022	12-31-2021	10-K
12	11-05-2021	09-30-2021	10-Q
13	08-10-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	03-30-2021	12-31-2020	10-K
16	11-06-2020	09-30-2020	10-Q
17	08-07-2020	06-30-2020	10-Q
18	05-08-2020	03-31-2020	10-Q
19	03-09-2020	12-31-2019	10-K
20	11-12-2019	09-30-2019	10-Q
21	08-13-2019	06-30-2019	10-Q
22	05-13-2019	03-31-2019	10-Q
23	03-13-2019	12-31-2018	10-K
24	11-13-2018	09-30-2018	10-Q
25	08-30-2018	06-30-2018	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Buy on Crine...
08/09/2024 20:58:15

HC Wainwright & Co. analyst Douglas Tsao maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and raises the pri...

A Closer Look at 11 Analyst Recommendation...
08/09/2024 16:00:49

Oppenheimer Reiterates Outperform on Crine...
08/09/2024 15:20:00

Oppenheimer analyst Leland Gershell reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and lowers the pric...

Crinetics Expects Cash & Equivalents To Be...
08/08/2024 21:15:16

Crinetics Says Marc Wilson Will Be Transit...
08/08/2024 21:14:36

Crinetics Pharmaceuticals Q2 2024 GAAP EPS...
08/08/2024 20:39:05

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.94) per share which missed the analyst consensus estim...

xpeng--quantumscape-are-among-top-11-mid-cap-stocks-that-performed-well-last-week-july-7-july-13-details

XPeng & QuantumScape Are Among Top 11 Mid ...
07/14/2024 17:22:37

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...

JP Morgan Maintains Overweight on Crinetic...
07/09/2024 14:59:04

JP Morgan analyst Jessica Fye maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the price targe...

Piper Sandler Maintains Overweight on Crin...
07/02/2024 17:29:11

Piper Sandler analyst Yasmeen Rahimi maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and maintains $97 p...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
07/01/2024 17:35:22

Forecasting The Future: 11 Analyst Project...
06/28/2024 17:01:20

HC Wainwright & Co. Reiterates Buy on Crin...
06/28/2024 10:48:07

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

nvidia-to-rally-around-11-here-are-10-top-analyst-forecasts-for-tuesday

Nvidia To Rally Around 11%? Here Are 10 To...
06/04/2024 12:20:36

JMP Securities Reiterates Market Outperfor...
06/04/2024 12:19:30

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

Oppenheimer Maintains Outperform on Crinet...
06/04/2024 12:08:22

Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price...

17 Analysts Have This To Say About Crineti...
06/04/2024 12:01:33

HC Wainwright & Co. Reiterates Buy on Crin...
06/04/2024 11:26:54

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

Crinetics To Present New Data Results Of T...
06/03/2024 16:02:02

First Scientific Presentation of PATHFNDR-2 Acromegaly Safety and Efficacy Data Following Positive Topline Announcement, Showin...

Baird Maintains Outperform on Crinetics Ph...
05/23/2024 16:37:36

Baird analyst Brian Skorney maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price target ...

Morgan Stanley Maintains Overweight on Cri...
05/23/2024 15:23:26

Morgan Stanley analyst Jeffrey Hung maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the price...